NCT03242902View on ClinicalTrials.gov

To Decrease Fatigue With Light Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

November 25, 2019

Study Completion Date

August 11, 2020

Conditions
Hodgkin LymphomaDiffuse Large B Cell Lymphoma
Interventions
DEVICE

Light therapy intensity 1

Exposure to white light (10.000 lux) in the morning

DEVICE

Light therapy intensity 2

Exposure to white light (10-20 lux) in the morning

Trial Locations (9)

6500 HB

Radboudumc, Nijmegen

1066 CX

Netherlands Cancer Institute, Amsterdam

1081 HV

VUmc, Amsterdam

2300 RC

Leids Universitair Medisch Centrum, Leiden

3000 CA

Erasmus MC, Rotterdam

3300 AK

Albert Schweitzer Ziekenhuis, Dordrecht

3318 AT

Admiraal de Ruyter ziekenhuis, Goes

2545 CH

Haga ziekenhuis, The Hague

2508 GA

Universitair Medisch Centrum Utrecht, Utrecht

All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

lead

The Netherlands Cancer Institute

OTHER

NCT03242902 - To Decrease Fatigue With Light Therapy | Biotech Hunter | Biotech Hunter